Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocuphire Pharma Inc
(NQ:
OCUP
)
1.330
+0.090 (+7.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocuphire Pharma Inc
< Previous
1
2
3
4
Next >
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
June 14, 2024
These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist.
Via
Talk Markets
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
May 22, 2024
Via
Benzinga
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q1 2024
May 10, 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
April 11, 2024
Via
Benzinga
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
March 26, 2024
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: Ocuphire Pharma Q3 Earnings
November 13, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
May 22, 2023
Via
Benzinga
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q4 2023
March 15, 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
Via
InvestorPlace
3 Value Stocks to Buy on the Dip: February 2024
February 07, 2024
While many investors continue to chase after the latest trends, these underappreciated value stocks to buy could be the true winners.
Via
InvestorPlace
Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024
November 30, 2023
Often the best investments are out-of-favor and trade at silly cheap valuations. Check out three such growth stocks with huge upside.
Via
InvestorPlace
A Look Into Healthcare Sector Value Stocks
November 20, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
May 01, 2023
Via
Benzinga
Ocuphire Pharma Inc. (NASDAQ: OCUP) Highlighted for Surprising Price Action
April 04, 2023
Via
Investor Brand Network
Overview Of Value Stocks In The Healthcare Sector
November 06, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
September 11, 2023
Via
Benzinga
Surprise! These 3 Penny Stocks Pack Powerful Financials.
July 10, 2023
While investing in penny stocks carries a rough reputation (to put it nicely), these speculative entities just might surprise you.
Via
InvestorPlace
The 7 Best Stocks Under $10 to Buy in May
May 03, 2023
While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough.
Via
InvestorPlace
7 Small-Cap Biotech Stocks with Massive Potential
April 27, 2023
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.
Via
InvestorPlace
Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case
April 21, 2023
Ocuphire Pharma Inc (NASDAQ: OCUP) was plunging over 22% at one point on Friday after the company announced it appointed Rick Rodgers to the role of interim CEO.
Via
Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 21, 2023
Via
Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
April 21, 2023
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
April 05, 2023
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 04, 2023
Via
Benzinga
Ocuphire Pharma, Inc. (NASDAQ: OCUP) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference
February 22, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 27, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.